27.11.2012 Views

BioWorld® - Medical Device Daily

BioWorld® - Medical Device Daily

BioWorld® - Medical Device Daily

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information<br />

Immunicon Corp. reagents for the<br />

detection of undisclosed<br />

antigens on circulating<br />

tumor cells (CTCs)<br />

R&D agreement;<br />

amended 4/04,<br />

expanded 12/04,<br />

extended 3/06<br />

Immusol Inc. target validation<br />

collaboration<br />

Incyte Corp. Incyte's LifeSeq database<br />

genomics database, subscription (6/94),<br />

expanded to include extended three<br />

LifeSeq FL database years and<br />

and LifeSeq<br />

GeneAlbum DNA clone<br />

set<br />

expandedexpanded<br />

Incyte Corp. development,<br />

manufacture and<br />

marketing of novel oral<br />

Inhale Therapeutic<br />

Systems<br />

CCR2 antagonists<br />

pulmonary delivery<br />

system for insulin<br />

Inpharmatica Ltd. identification,<br />

prioritization and<br />

validation of the<br />

suitability of drug<br />

Isis<br />

Pharmaceuticals<br />

targets<br />

identification of secondgeneration<br />

antisense<br />

drugs for the treatment<br />

of ophthalmic disease<br />

LifeSpan<br />

LifeSpan's DrugTarget<br />

BioSciences Inc. Database<br />

Medarex Inc. up to 50 antibody<br />

products over 10 years<br />

Metabasis adenosine regulating<br />

Therapeutics Inc. agents (ARA) as broad-<br />

(Gensia Sicor Inc.) spectrum analgesic<br />

drugs for treating pain<br />

Microcide<br />

Pharmaceuticals<br />

Inc.<br />

Microcide<br />

Pharmaceuticals<br />

Inc.<br />

antibiotic for animal<br />

health applications<br />

drugs to treat resistant<br />

bacterial infections<br />

research and<br />

license agreement<br />

development<br />

agreement,<br />

completed Phase I<br />

clinicals<br />

subscription<br />

agreement<br />

multi-year drug<br />

discovery<br />

collaboration--Isis<br />

will receive a $1M<br />

technology access<br />

fee, research<br />

funding, milestone<br />

payments and<br />

royalties<br />

multiyear<br />

agreement<br />

development and<br />

licensing agreement<br />

research<br />

collaboration (5/96),<br />

extended through<br />

May 1999,<br />

Metabasis gets<br />

additional research<br />

funding plus<br />

milestones and<br />

royalties if Pfizer<br />

selects product for<br />

clinical<br />

development<br />

research<br />

collaboration<br />

five-year<br />

collaboration (3/96),<br />

Microcide received<br />

$1M milestone<br />

payment related to<br />

identification,<br />

validation and<br />

sequencing of<br />

genes<br />

Copyright ©2006 AHC Media ® 311<br />

2/03<br />

3/98<br />

2/98<br />

11/05<br />

1/95<br />

2/01<br />

5/05<br />

12/05<br />

9/04<br />

3/98<br />

1/99<br />

2/97

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!